Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF

Leukemia, Published online: 12 March 2024; doi:10.1038/s41375-024-02215-9Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF

Source: Leukemia - March 12, 2024 Category: Hematology Authors: Daniela Žáčková Luk áš Semerád Edgar Faber Hana Klamov á Luk áš Stejskal Petra B ělohlávková Michal Karas Eduard Cmunt Olga Černá Ji řina Procházková Petra Čičátková Ane žka Kvetková Tom áš Horňák Ivana Skoumalov á Dana Srbov Source Type: research